Recent research highlights the pivotal role of ELOVL1 in T cell cholesterol metabolism and its implications for enhancin...
Tailored antisense oligonucleotides (ASOs) are changing the future of rare genetic disease therapies
Rare diseases affect hundreds of millions worldwide, with most cases having genetic origins and primarily impacting chil...
New breakthroughs in early-onset dementia: progranulin therapies show promise
A groundbreaking development in the fight against frontotemporal dementia (FTD) is opening up new avenues for drug disco...
Empowering the Future: Biotech and Sustainable Development
Biotech Future 2025 On the occasion of the Made in Italy Day, Federchimica Assobiotec and Università degli Studi di Nap...
Breaking Barriers in dyslipideamia Treatment: A New Era of Lipid Management
Despite existing cholesterol-lowering therapies, a significant percentage of patients fail to reach guideline-recommende...
Ozgur Yaziyurt Appointed as the New Country President of Pfizer Italy
Rome, March 4, 2025 – Ozgur Yaziyurt has been appointed Country President of Pfizer in Italy, succeeding Päivi Kerkol...